Table 2. Comparison of prognostic stratification of the MESIAH score and the BCLC system.
| Model | C-statistic | LR χ2 | AIC |
|---|---|---|---|
| All patients (n=1,969) | |||
| MESIAH | 0.792 (0.782-0.803) | 1263.0 | 17523.0 |
| BCLC | 0.665 (0.653-0.678) | 551.9 | 18240.1 |
| CLIP | 0.760 (0.748-0.771) | 1031,6 | 17764.4 |
| JIS | 0.753 (0.748-0.771) | 1025.3 | 17768.8 |
| Tokyo score | 0.716 (0.703-0.729) | 688.4 | 18111.7 |
| Without transplantation (n=1,870) | |||
| MESIAH | 0.789(0.778-0.800) | 1207.7 | 17123.6 |
| BCLC | 0.666(0.653-0.678) | 556.9 | 17780.4 |
| CLIP | 0.760 (0.748-0.772) | 1003.4 | 17337.9 |
| JIS | 0.752 (0.741-0.764) | 1016.1 | 17323.2 |
| Tokyo score | 0.724 (0.711-0.737) | 745.8 | 17599.5 |
| HBV (n=1,469) | |||
| MESIAH | 0.797 (0.785-0.810) | 1015.8 | 12624.1 |
| BCLC | 0.669 (0.655-0.684) | 444.4 | 13201.5 |
| CLIP | 0.767 (0.754-0.780) | 856.0 | 12793.9 |
| JIS | 0.761 (0.748-0.773) | 853.8 | 12794.1 |
| Tokyo score | 0.724 (0.709-0.738) | 570.8 | 13083.1 |
| HCV (n=184) | |||
| MESIAH | 0.755 (0.712-0.797) | 86.4 | 1051.4 |
| BCLC | 0.636 (0.592-0.679) | 31.3 | 1112.5 |
| CLIP | 0.724 (0.679-0.768) | 73.8 | 1074.0 |
| JIS | 0.694 (0.647-0.740) | 54.3 | 1091.5 |
| Tokyo score | 0.685 (0.639-0.732) | 47.2 | 1102.7 |
| NBNC (n=316) | |||
| MESIAH | 0.784 (0.755-0.813) | 156.2 | 1950.3 |
| BCLC | 0.658 (0.626-0.691) | 78.6 | 2033.9 |
| CLIP | 0.731 (0.697-0.764) | 113.6 | 2002.9 |
| JIS | 0.730 (0.699-0.762) | 133.5 | 1981.0 |
| Tokyo score | 0.686 (0.651-0.722) | 84.3 | 2036.2 |
LR, likelihood ratio; AIC, Akaike information criterion; MESIAH, Model to Estimate Survival in Ambulatory HCC; BCLC, Barcelona Clinic Liver Cancer; HBV, hepatitis B virus; HCV, hepatitis C virus; NBNC, non-B non-C